West German Study Group
Clinical trials sponsored by West German Study Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a pill replace chemo for some breast cancer patients? Results expected Jul 2027 (estimated)
-
New hope for early breast cancer: targeted therapy may replace chemo
Disease control Recruiting nowThis phase 3 trial is testing whether a targeted drug called sacituzumab govitecan (Trodelvy), alone or combined with the immunotherapy pembrolizumab (Keytruda), can effectively treat low-risk triple-negative breast cancer before surgery. The study aims to see if these drugs can …
Phase 3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug combo could spare chemo for some breast cancer patients
Disease control Recruiting nowThis study tests a personalized treatment plan for people with HER2-positive early breast cancer. It compares a newer drug (trastuzumab-deruxtecan) against standard chemotherapy combinations to see which works better and causes fewer side effects. About 702 participants will rece…
Phase 2 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC